Nanolight has been developing a blood test that uses nanotechnology for rapid diagnosis in early stage breast cancer. We use of modified gold nanoparticles to detect the biomarker and emit fluorescent signal in positive cases that can be verified in routine laboratory equipment in clinical analysis.